Medical Communications

Showing 15 posts of 6402 posts found.

abbvieuse_054_low

AbbVie’s psoriasis drug smashes all endpoints

October 26, 2017 Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …
amber_hr_2

Is the NHS prepared for the upcoming winter season?

October 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …
doctor-840127_960_720

NHS patients could be offered Airbnb-like accommodation

October 26, 2017 Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …
alessandro-riva

Gilead promotes Alessandro Riva to Senior VP, Hematology and Oncology Therapeutic Area Head

October 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …

Recipharm equips Lisbon facility for US and European serialisation

October 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …
lauritzen1_k100

Securing the cold chain with new solutions

October 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cold chain, manufacturing, supply chain

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …
save_our_nhs

Pharma companies accused of charging NHS twice for treatments

October 23, 2017 Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

A new report published by STOP AIDS and Global Justice Now takes aim at three pharmaceutical companies who have taken …
antibiotics

Public Health England sounds warning against overuse of antibiotics

October 23, 2017 Medical Communications, Sales and Marketing Antibiotics, biotech, drugs, pharma, pharmaceutical

Public Health England (PHE) has unveiled the findings from its English surveillance programme for antimicrobial utilisation and resistance report, suggesting …
pollution_smoke

Report reveals impact of pollution, with 9m deaths worldwide

October 20, 2017 Medical Communications biotech, drugs, pharma, pharmaceutical, pollution

A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …
dna-1903319_960_720

Small number of mutations driving most cancers

October 20, 2017 Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …
teva_copy

Teva under investigation over illegal rebate offers to Ontario pharmacies

October 20, 2017 Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone

Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …
celgene_building

Celgene drops $710m drug, shares nosedive 7%

October 20, 2017 Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …
donor_card

Worrying number of organ donations blocked by families

October 19, 2017 Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …
The Gateway to Local Adoption Series

Latest content